Posted by Michael Wonder on 04 Aug 2021
Abbott receives FDA clearance for its imaging technology using artificial intelligence for vessels in the heart
3 August 2021 - Ultreon 1.0 software, the first-of-its-kind imaging software, merges optical coherence tomography with the power of automation using artificial intelligence.
Abbott today announced it has received U.S. FDA clearance for its latest optical coherence tomography imaging platform powered by the company's new Ultreon Software.
This innovative imaging software combines optical coherence tomography with artificial intelligence to provide physicians an enhanced, comprehensive view of coronary blood flow and blockages to assist physician decision-making and provide the best pathway for treatment.
